21 May 2009
Liver transplantation in two children with severe hepatic graft versus host disease after hematopoietic stem cell transplantation
J Teisseyre, M Teisseyre, P Kaliciński, B Wolska-Kusnierz, M Markiewicz-Kijewska, H Ismail, I Jankowska, M SzymczakAnn Transplant 2009; 14(1): 41-42 :: ID: 880349
Abstract
Backgound: Graft versus host disease (GVHD), a common complication of
hematopoietic stem cell transplantation (HSCT), frequently causes liver injury and in some cases leads to an end stage liver disease. Some authors have suggested that extra hepatic GVHD (skin and intestinal) should be a contraindication to liver transplantation (OLTx) because of a poor survival of these patients. The aim of the study is to present a successful OLTx in two patients with severe chronic GVHD after HSCT.
Material/Method: First case: 8- years-old boy received MUD HSCT due to CD40
ligand deficiency complicated by chronic Cryptosporidium infection with cholangitis sclerosans. GVHD III/IV degree occured 8 days after HSCT. Vanishing bile duct syndrome caused liver failure. Successful OLTx was performed 11 months later after resolution of skin and intestinal symptoms of GVHD. Second case: 6 month old boy with X-linked severe combined immunodeficiency received MUT HSCT. GVHD III degree occured 26 days after HSCT. Six months later, when skin and intestinal symptoms had been resolved, living related OLTx was successfully performed due to an end stage liver involvement.
Results: Both patients have good liver function, full immunological reconstitution and haven't GVHD symptoms respectively six months and four years after OLTx. Conclusions: OLTx appears to be an effective treatment for post HSCT GVHD even when both hepatic and extra hepatic symptoms are present.
Keywords: Liver Transplantation, Stem Cell Transplantation, case report
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860